BIO3:F Biotest Aktiengesellschaft

EUR 28.40 -0.30 -1.045296
Icon

Biotest Aktiengesellschaft (BIO3:F) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 28.40

-0.30 (-1.05)%

EUR 1.52B

25.00

N/A

N/A

Icon

BIO3:F

Biotest Aktiengesellschaft (EUR)
COMMON STOCK | F
EUR 28.40
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 1.52B

N/A

EUR 28.40

Biotest Aktiengesellschaft (BIO3:F) Stock Forecast

N/A

Based on the Biotest Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Biotest Aktiengesellschaft is not available over the next 12 months. Biotest Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biotest Aktiengesellschaft is Slightly Bullish , which is based on 6 positive signals and 3 negative signals. At the last closing, Biotest Aktiengesellschaft’s stock price was EUR 28.40. Biotest Aktiengesellschaft’s stock price has changed by -0.35% over the past week, +15.45% over the past month and -6.58% over the last year.

No recent analyst target price found for Biotest Aktiengesellschaft
No recent average analyst rating found for Biotest Aktiengesellschaft

Company Overview Biotest Aktiengesellschaft

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine ar...Read More

https://www.biotest.com

Landsteinerstrasse 5, Dreieich, Germany, 63303

2,228

December

EUR

Germany

Adjusted Closing Price for Biotest Aktiengesellschaft (BIO3:F)

Loading...

Unadjusted Closing Price for Biotest Aktiengesellschaft (BIO3:F)

Loading...

Share Trading Volume for Biotest Aktiengesellschaft Shares

Loading...

Compare Performance of Biotest Aktiengesellschaft Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIO3:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biotest Aktiengesellschaft (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOVA:F
Novo Nordisk A/S -1.00 (-0.86%) EUR525.74B 45.80 4.49

ETFs Containing BIO3

Symbol Name BIO3's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biotest Aktiengesellschaft (BIO3:F) Stock

Stock Target Advisor's fundamental analysis for Biotest Aktiengesellschaft's stock is Slightly Bullish .

Unfortunately we do not have enough data on BIO3:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIO3:F's stock to indicate what its average analyst target is.

BIO3:F stock's Price/Earning ratio is 12.84. Our analysis grades BIO3:F stock's Price / Earning ratio at D. This means that BIO3:F stock's Price/Earning ratio is above 37% of the stocks in the Biotechnology sector in the F exchange. Based on this BIO3:F may be fairly valued for its sector

The last closing price of BIO3:F's stock was EUR 28.40.

The most recent market capitalization for BIO3:F is EUR 1.52B.

Unfortunately we do not have enough analyst data on BIO3:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biotest Aktiengesellschaft's stock.

As per our most recent records Biotest Aktiengesellschaft has 2,228 Employees.

Biotest Aktiengesellschaft's registered address is Landsteinerstrasse 5, Dreieich, Germany, 63303. You can get more information about it from Biotest Aktiengesellschaft's website at https://www.biotest.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...